September 13, 2024
APC supports upcoming DEA guidance on constructive transfer
Some good news: DEA is set to issue new guidance on constructive transfer that would allow the dispensing or delivery of controlled substances to a practitioner’s office if the patient and practitioner execute a power of attorney. That POA would authorize the practitioner to receive the medication on the patient’s behalf for administration in the practitioner’s office.
This much-needed guidance will remove significant barriers to patient access and ensure the safe delivery of life-sustaining medications to patients that depend on them. APC sent a letter to DEA this week supporting the decision — and as soon as the guidance is issued, we’ll update our briefing on constructive transfer.